555 related articles for article (PubMed ID: 27288457)
1. Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
Lopez-Anido C; Poitelon Y; Gopinath C; Moran JJ; Ma KH; Law WD; Antonellis A; Feltri ML; Svaren J
Hum Mol Genet; 2016 Jul; 25(14):3055-3069. PubMed ID: 27288457
[TBL] [Abstract][Full Text] [Related]
2. Regulation of myelin-specific gene expression. Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the PMP22 gene through an intronic enhancer.
Jones EA; Lopez-Anido C; Srinivasan R; Krueger C; Chang LW; Nagarajan R; Svaren J
J Neurosci; 2011 Mar; 31(11):4242-50. PubMed ID: 21411665
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the neuropathy-associated Pmp22 gene by a distal super-enhancer.
Pantera H; Moran JJ; Hung HA; Pak E; Dutra A; Svaren J
Hum Mol Genet; 2018 Aug; 27(16):2830-2839. PubMed ID: 29771329
[TBL] [Abstract][Full Text] [Related]
5. Dynamic regulation of Schwann cell enhancers after peripheral nerve injury.
Hung HA; Sun G; Keles S; Svaren J
J Biol Chem; 2015 Mar; 290(11):6937-50. PubMed ID: 25614629
[TBL] [Abstract][Full Text] [Related]
6. Pmp22 super-enhancer deletion causes tomacula formation and conduction block in peripheral nerves.
Pantera H; Hu B; Moiseev D; Dunham C; Rashid J; Moran JJ; Krentz K; Rubinstein CD; Won S; Li J; Svaren J
Hum Mol Genet; 2020 Jun; 29(10):1689-1699. PubMed ID: 32356557
[TBL] [Abstract][Full Text] [Related]
7. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A.
Perea J; Robertson A; Tolmachova T; Muddle J; King RH; Ponsford S; Thomas PK; Huxley C
Hum Mol Genet; 2001 May; 10(10):1007-18. PubMed ID: 11331611
[TBL] [Abstract][Full Text] [Related]
8. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
[TBL] [Abstract][Full Text] [Related]
9. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
[TBL] [Abstract][Full Text] [Related]
10. Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
Lee JS; Lee JY; Song DW; Bae HS; Doo HM; Yu HS; Lee KJ; Kim HK; Hwang H; Kwak G; Kim D; Kim S; Hong YB; Lee JM; Choi BO
Nucleic Acids Res; 2020 Jan; 48(1):130-140. PubMed ID: 31713617
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy.
Hanemann CO; Müller HW
Trends Neurosci; 1998 Jul; 21(7):282-6. PubMed ID: 9683317
[TBL] [Abstract][Full Text] [Related]
12. New vistas on the pathomechanism of Charcot-Marie-Tooth and related peripheral neuropathies.
Müller HW
Ann N Y Acad Sci; 1999 Sep; 883():152-9. PubMed ID: 10586241
[TBL] [Abstract][Full Text] [Related]
13. SOX10 regulates an alternative promoter at the Charcot-Marie-Tooth disease locus MTMR2.
Fogarty EA; Brewer MH; Rodriguez-Molina JF; Law WD; Ma KH; Steinberg NM; Svaren J; Antonellis A
Hum Mol Genet; 2016 Sep; 25(18):3925-3936. PubMed ID: 27466180
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
Sancho S; Young P; Suter U
Brain; 2001 Nov; 124(Pt 11):2177-87. PubMed ID: 11673320
[TBL] [Abstract][Full Text] [Related]
15. Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons.
Maier M; Castagner F; Berger P; Suter U
Mol Cell Neurosci; 2003 Nov; 24(3):803-17. PubMed ID: 14664827
[TBL] [Abstract][Full Text] [Related]
16. Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10.
LeBlanc SE; Ward RM; Svaren J
Mol Cell Biol; 2007 May; 27(9):3521-9. PubMed ID: 17325040
[TBL] [Abstract][Full Text] [Related]
17. A novel case of concurrent occurrence of demyelinating-polyneuropathy-causing PMP22 duplication and SOX10 gene mutation producing severe hypertrophic neuropathy.
Matsuda N; Ootsuki K; Kobayashi S; Nemoto A; Kubo H; Usami SI; Kanani K
BMC Neurol; 2021 Jun; 21(1):243. PubMed ID: 34171997
[TBL] [Abstract][Full Text] [Related]
18. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
Niemann A; Berger P; Suter U
Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
[TBL] [Abstract][Full Text] [Related]
19. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
[TBL] [Abstract][Full Text] [Related]
20. PMP22 expression in dermal nerve myelin from patients with CMT1A.
Katona I; Wu X; Feely SM; Sottile S; Siskind CE; Miller LJ; Shy ME; Li J
Brain; 2009 Jul; 132(Pt 7):1734-40. PubMed ID: 19447823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
